Description  Claims  Cited references 

WO2012118812A   [0004] 
US6106864A   [0335] 
WO0035298A   [0335] 
WO9111172A   [0356] 
WO9402518PCT   [0356] 
WO9855148PCT   [0356] 

Crit. Rev. Oncol. Hematol.   [0003] 
Proc. Natl. Acad. Sci. USA   [0003] 
Eur. J. Surg. Oncol.   [0003] 
J. Clin. Oncol.   [0003] 
Cancer Sci.   [0003] 
Lab. Invest.   [0003] 
Br. J. Cancer   [0003] 
Neoplasia   [0003] 
Cancer Res.   [0003] 
Clin. Cancer Res.   [0003] 
Nature   [0003] 
Int. J. Cancer   [0003] 
Int. J. Mol. Med.   [0003] 
Nat. Genetics   [0004] 
Proc. Natl. Acad. Sci. USA   [0004] 
FEBS Letters   [0004] 
Handbook of Pharmaceutical Salts: Properties, Selection, and Use   [0258] 
J Pharm Sci   [0262] 
Pro-drugs as Novel Delivery Systems   [0263] 
Bioreversible Carriers in Drug Design   [0263] 
Design of Prodrugs   [0264] 
Stereochemistry of Organic Compounds   [0279] 
Remington's Pharmaceutical Sciences   [0321] 
Expert Opinion in Therapeutic Patents   [0325] 
Pharmaceutical Dosage Forms: Tablets   [0333] 
Pharmaceutical Technology On-line   [0335] 
J Pharm Sci   [0341] 
CHEMICAL ABSTRACTS   [0503]